Viewing Study NCT04146259


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2025-12-24 @ 2:49 PM
Study NCT ID: NCT04146259
Status: COMPLETED
Last Update Posted: 2019-11-01
First Post: 2019-10-29
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism
Sponsor: University of Athens
Organization:

Study Overview

Official Title: Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism
Status: COMPLETED
Status Verified Date: 2019-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To investigate changes in sclerostin levels following acute post-thyroidectomy hypoparathyroidism
Detailed Description: Female patients with thyroid disorders, referred to the Department of Head and Neck Surgery, at Metaxa Anti-Cancer Hospital of Piraeus, for total thyroidectomy.

Based on the development of biochemical hypocalcemia (cCa \< 8.4 mg/dl), subjects were divided into 2 groups: Group A: without postsurgical hypoparathyroidism that served as controls and group B: subjects, with acute postsurgical hypoparathyroidism.

Blood collections were performed in the morning after an overnight fast, in at least 3 different time points; preoperatively, 1st postoperative day and 7th postoperative day for the detrmination of sclerostin levels

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: